SLC26A4 and chronic obstructive pulmonary disease: In recent years, pendrin gain of function, mainly due to increased surface expression, has been linked to respiratory diseases including bronchial asthma, COPD, and rhinovirus infection, rhinitis, and chronic rhinosinusitis [54, 55, 81–86].